Please wait...
About This Project
Therapeutics in any modality to combat Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections are in urgent demand across the entire world as the Coronavirus Disease 2019 (COVID-19) pandemic continues to interrupt the well-being of human life. Without clinical therapeutics available for any of the human coronaviruses, a key starting point is to focus on target-based high-throughput screening (HTS) to reveal potent anti-SARS-CoV-2 hit-to-leads that are safe to human cells.
More Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Does bias about medical diagnosis link to expectations of mental health problems for infants and their parents?
If doctors think infants will have lower skill (e.g., less able to look and to smile at parents), does that...
Can Tampons Deliver Pain Relief?
Menstrual cramps significantly disrupt daily life for millions of women. To address this, I'm developing...
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...